{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:07:18Z","timestamp":1790381238656,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bbrep.2025.101916","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T16:46:39Z","timestamp":1736441199000},"page":"101916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A comprehensive outline of the role of non-coding RNAs in vitiligo"],"prefix":"10.1016","volume":"41","author":[{"given":"Fateme Sadat","family":"Feghahati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0223-499X","authenticated-orcid":false,"given":"Soudeh","family":"Ghafouri-Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbrep.2025.101916_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jamadermatol.2021.4724","article-title":"Prevalence of vitiligo among adults in the United States","volume":"158","author":"Gandhi","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.bbrep.2025.101916_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/cei\/uxab002","article-title":"Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors","volume":"207","author":"Faraj","year":"2022","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.bbrep.2025.101916_bib3","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the vitiligo global issues consensus conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigm. cell. melanoma res."},{"issue":"2","key":"10.1016\/j.bbrep.2025.101916_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.det.2016.11.013","article-title":"Genetics of vitiligo","volume":"35","author":"Spritz","year":"2017","journal-title":"Dermatol. Clin."},{"issue":"2","key":"10.1016\/j.bbrep.2025.101916_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jid.2020.06.004","article-title":"The genetic basis of vitiligo","volume":"141","author":"Spritz","year":"2021","journal-title":"J. Invest. Dermatol."},{"issue":"18","key":"10.1016\/j.bbrep.2025.101916_bib6","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJMoa0908547","article-title":"Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo","volume":"362","author":"Jin","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bbrep.2025.101916_bib7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/ng.602","article-title":"Common variants in FOXP1 are associated with generalized vitiligo","volume":"42","author":"Jin","year":"2010","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.bbrep.2025.101916_bib8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng.2272","article-title":"Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo","volume":"44","author":"Jin","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrep.2025.101916_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102982","article-title":"Non-coding RNAs in immunoregulation and autoimmunity: Technological advances and critical limitations","volume":"134","author":"Kumar","year":"2023","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.bbrep.2025.101916_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/biom10071044","article-title":"Long noncoding RNAs and circular RNAs in autoimmune diseases","volume":"10","author":"Lodde","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bbrep.2025.101916_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95466-w","article-title":"Dysregulation of lncRNAs in autoimmune neuropathies","volume":"11","author":"Gholipour","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbrep.2025.101916_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jcp.25056","article-title":"MicroRNA as biomarkers and Diagnostics","volume":"231","author":"Wang","year":"2016","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bbrep.2025.101916_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21608\/scumj.2023.283958","article-title":"A study of plasma miR-23a expression in vitiligo patients","volume":"26","author":"Salman","year":"2023","journal-title":"Suez Canal Univ. Med. J."},{"issue":"2","key":"10.1016\/j.bbrep.2025.101916_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jdermsci.2023.12.006","article-title":"Exosomes containing miR-1469 regulate natural killer cells by targeting CD122 in non-segmental vitiligo","volume":"113","author":"Wei","year":"2024","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.bbrep.2025.101916_bib15","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2020.11689","article-title":"MicroRNA-21-5p protects melanocytes via targeting STAT3 and modulating Treg\/Teff balance to alleviate vitiligo","volume":"23","author":"Huo","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.bbrep.2025.101916_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s40291-023-00646-1","article-title":"Expression signature of immune-related MicroRNAs in autoimmune skin disease: psoriasis and vitiligo insights","volume":"27","author":"Abdallah","year":"2023","journal-title":"Mol. Diagn. Ther."},{"issue":"2","key":"10.1016\/j.bbrep.2025.101916_bib17","first-page":"858","article-title":"\u039cicroRNA-421 participates in vitiligo development through regulating human melanocyte survival by targeting receptor-interacting serine\/threonine kinase 1","volume":"21","author":"Sun","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bbrep.2025.101916_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17770-3","article-title":"Investigating melanogenesis-related microRNAs as disease biomarkers in vitiligo","volume":"12","author":"Abdallah","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2025.101916_bib19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00403-024-02847-y","article-title":"Association between miR-202, miR-211, and miR-1238 gene polymorphisms and risk of vitiligo","volume":"316","author":"Shahroudi","year":"2024","journal-title":"Arch. Dermatol. Res."},{"issue":"6","key":"10.1016\/j.bbrep.2025.101916_bib20","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/bjd.19666","article-title":"The long noncoding RNA MALAT1 suppresses miR-211 to confer protection from ultraviolet-mediated DNA damage in vitiligo epidermis by upregulating sirtuin 1","volume":"184","author":"Brahmbhatt","year":"2021","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"10.1016\/j.bbrep.2025.101916_bib21","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.jid.2017.04.025","article-title":"MicroRNA-211 regulates oxidative phosphorylation and energy metabolism in human vitiligo","volume":"137","author":"Sahoo","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"10","key":"10.1016\/j.bbrep.2025.101916_bib22","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/1346-8138.13886","article-title":"Altered expression of four miRNA (miR-1238-3p, miR-202-3p, miR-630 and miR-766-3p) and their potential targets in peripheral blood from vitiligo patients","volume":"44","author":"Shang","year":"2017","journal-title":"J. Dermatol."},{"issue":"12","key":"10.1016\/j.bbrep.2025.101916_bib23","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1016\/j.jid.2022.05.1086","article-title":"Circulating exosomal miR-493-3p affects melanocyte survival and function by regulating epidermal dopamine concentration in segmental vitiligo","volume":"142","author":"Li","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbrep.2025.101916_bib24","series-title":"Expression of MicroRNA-224-3p in Vitiligo","author":"El-Rifaie","year":"2021"},{"issue":"8","key":"10.1016\/j.bbrep.2025.101916_bib25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/15257770.2022.2066126","article-title":"MicroRNA-183-5p regulates MITF expression in vitiligo skin depigmentation","volume":"41","author":"Al Robaee","year":"2022","journal-title":"Nucleosides, Nucleotides Nucleic Acids"},{"issue":"20","key":"10.1016\/j.bbrep.2025.101916_bib26","doi-asserted-by":"crossref","first-page":"12164","DOI":"10.1111\/jcmm.15864","article-title":"Down-regulation of exosomal miR-200c derived from keratinocytes in vitiligo lesions suppresses melanogenesis","volume":"24","author":"Zhao","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbrep.2025.101916_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6832680","article-title":"Study on the mechanism of miR-125b-5p affecting melanocyte biological behavior and melanogenesis in vitiligo through regulation of MITF","volume":"2022","author":"Wang","year":"2022","journal-title":"Dis. Markers"},{"issue":"2","key":"10.1016\/j.bbrep.2025.101916_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/JEWD.JEWD_19_19","article-title":"MicroRNA-146a and Forkhead box protein 3 expressions in nonsegmental vitiligo: an insight into disease pathogenesis","volume":"16","author":"Hassan","year":"2019","journal-title":"J. Egypt. Women\u2019s Dermatol. Soc."},{"issue":"3","key":"10.1016\/j.bbrep.2025.101916_bib29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/cdd.2015.117","article-title":"Oxidative stress-induced overexpression of miR-25: the mechanism underlying the degeneration of melanocytes in vitiligo","volume":"23","author":"Shi","year":"2016","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.bbrep.2025.101916_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/ijd.15669","article-title":"Association between long noncoding RNA taurine-upregulated gene 1 and microRNA-377 in vitiligo","volume":"61","author":"Alhelf","year":"2022","journal-title":"Int. J. Dermatol."},{"issue":"3","key":"10.1016\/j.bbrep.2025.101916_bib31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/JEWD.JEWD_31_20","article-title":"Expression of long noncoding RNA in skin exosomes of patients with vitiligo","volume":"17","author":"Doss","year":"2020","journal-title":"J. Egypt. Women\u2019s Dermatol. Soc."},{"key":"10.1016\/j.bbrep.2025.101916_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12935-019-0927-6","article-title":"NEAT1\/miR-23a-3p\/KLF3: a novel regulatory axis in melanoma cancer progression","volume":"19","author":"Ding","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"51","key":"10.1016\/j.bbrep.2025.101916_bib33","article-title":"Expression patterns of long non-coding RNAs in peripheral blood mononuclear cells of non-segmental vitiligo","volume":"100","author":"Zhang","year":"2021","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.bbrep.2025.101916_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/2440377","article-title":"Increased expression of long noncoding RNA LOC100506314 in T cells from patients with nonsegmental vitiligo and its contribution to vitiligo pathogenesis","volume":"2023","author":"Lai","year":"2023","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbrep.2025.101916_bib35","article-title":"Identification of a potentially functional circRNA-miRNA-mRNA regulatory network in melanocytes for investigating pathogenesis of vitiligo","volume":"12","author":"Li","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbrep.2025.101916_bib36","article-title":"Differentially expressed circular RNAs and their therapeutic mechanism in non-segmental vitiligo patients treated with methylprednisolone","volume":"9","author":"Zhang","year":"2022","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.bbrep.2025.101916_bib37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40659-020-0272-1","article-title":"The comprehensive detection of miRNA, lncRNA, and circRNA in regulation of mouse melanocyte and skin development","volume":"53","author":"Zhu","year":"2020","journal-title":"Biol. Res."},{"key":"10.1016\/j.bbrep.2025.101916_bib38","first-page":"785","article-title":"Expression profile and bioinformatics analysis of circular RNAs in patients with vitiligo","volume":"15","author":"Zhang","year":"2022","journal-title":"Pharmgenom. Pers Med"},{"issue":"3","key":"10.1016\/j.bbrep.2025.101916_bib39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/CMR.0000000000000573","article-title":"Melanoma and autoimmunity: spontaneous regressions as a possible model for new therapeutic approaches","volume":"29","author":"Motofei","year":"2019","journal-title":"Melanoma Res."},{"issue":"5","key":"10.1016\/j.bbrep.2025.101916_bib40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s40257-020-00524-0","article-title":"Vitiligo and melanoma-associated vitiligo: understanding their similarities and differences","volume":"21","author":"Cohen","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"issue":"9","key":"10.1016\/j.bbrep.2025.101916_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256629","article-title":"Loss of miR-1469 expression mediates melanoma cell migration and invasion","volume":"16","author":"DiVincenzo","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2025.101916_bib42","series-title":"miR-21-5p Promotes Cell Proliferation and G1\/S Transition in Melanoma by Targeting CDKN2C","author":"Zhaohui Yang","year":"2020"},{"issue":"6","key":"10.1016\/j.bbrep.2025.101916_bib43","article-title":"MicroRNA-155 and disease-related immunohistochemical parameters in cutaneous melanoma","volume":"13","author":"Fawzy","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.bbrep.2025.101916_bib44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/CMR.0000000000000931","article-title":"The effect of microRNA-9 overexpression on inhibition of melanoma cancer stem cells tumorigenicity","volume":"34","author":"Parisa","year":"2024","journal-title":"Melanoma Res."},{"key":"10.1016\/j.bbrep.2025.101916_bib45","doi-asserted-by":"crossref","first-page":"9975","DOI":"10.2147\/OTT.S225120","article-title":"miR-124 functions as A melanoma tumor suppressor by targeting RACK1","volume":"12","author":"Shen","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.bbrep.2025.101916_bib46","series-title":"miR-145 Overexpression Suppresses the Migration and Invasion of Metastatic Melanoma Cells","author":"Gele","year":"2013"},{"key":"10.1016\/j.bbrep.2025.101916_bib47","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.12659\/MSM.894826","article-title":"Down-regulation of miR-148a promotes metastasis by DNA methylation and is associated with prognosis of skin cancer by targeting TGIF2","volume":"21","author":"Tian","year":"2015","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.1016\/j.bbrep.2025.101916_bib48","first-page":"2071","article-title":"MiR-320a inhibits malignant phenotype of melanoma cells via targeting PBX3","volume":"25","author":"Fu","year":"2020","journal-title":"J BUON"},{"issue":"3","key":"10.1016\/j.bbrep.2025.101916_bib49","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/jid.2012.357","article-title":"miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes","volume":"133","author":"Luo","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.bbrep.2025.101916_bib50","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317701640","article-title":"Downregulation of miR-493 promoted melanoma proliferation by suppressing IRS4 expression","volume":"39","author":"Cui","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1016\/j.bbrep.2025.101916_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154772","article-title":"miR-224\u20135p acts as a tumour suppressor and reverses the resistance to BRAF inhibitor in melanoma through directly targeting PAK4 to block the MAPK pathway","volume":"249","author":"Liu","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"2","key":"10.1016\/j.bbrep.2025.101916_bib52","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.18632\/oncotarget.13862","article-title":"Deregulation of miR-183 promotes melanoma development via lncRNA MALAT1 regulation and ITGB1 signal activation","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.bbrep.2025.101916_bib53","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.ajpath.2012.07.009","article-title":"miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1","volume":"181","author":"Liu","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"22","key":"10.1016\/j.bbrep.2025.101916_bib54","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1101\/gad.248377.114","article-title":"miR-125b can enhance skin tumor initiation and promote malignant progression by repressing differentiation and prolonging cell survival","volume":"28","author":"Zhang","year":"2014","journal-title":"Genes Dev."},{"issue":"34 Focus issue F1","key":"10.1016\/j.bbrep.2025.101916_bib55","first-page":"59","article-title":"miR-25 Promotes Melanoma Progression by regulating RNA binding motif protein 47","author":"Jiang","year":"2018","journal-title":"Med. Sci."},{"key":"10.1016\/j.bbrep.2025.101916_bib56","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12943-015-0338-9","article-title":"MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma","volume":"14","author":"Zehavi","year":"2015","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.bbrep.2025.101916_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/cells12060936","article-title":"The role of oxidative stress in vitiligo: an update on its pathogenesis and therapeutic implications","volume":"12","author":"Chang","year":"2023","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.bbrep.2025.101916_bib58","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/ced.14490","article-title":"Integrating neuronal involvement into the immune and genetic paradigm of vitiligo","volume":"46","author":"Al Abadie","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"issue":"7","key":"10.1016\/j.bbrep.2025.101916_bib59","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/CM9.0000000000001900","article-title":"Update on the role of noncoding RNAs in vitiligo","volume":"135","author":"Zhou","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.bbrep.2025.101916_bib60","article-title":"Exosome-derived microRNAs: emerging players in vitiligo","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbrep.2025.101916_bib61","first-page":"1017","article-title":"Role of the p53-TRPM1\/miR-211-MMP9 axis in UVB-induced human melanocyte migration and its potential in repigmentation","volume":"45","author":"Su","year":"2020","journal-title":"Int. J. Mol. Med."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825000032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825000032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:07:21Z","timestamp":1773864441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580825000032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":61,"alternative-id":["S2405580825000032"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.101916","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive outline of the role of non-coding RNAs in vitiligo","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.101916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101916"}}